- Filed
- Oct 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 15, 2025 | 46.95M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2025 | 47.5M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2025 | 47.4M sh |
| Shares Diluted | Q3 2025 · Sep 29, 2024 | 47.3M sh |
| Shares Diluted | Q3 2025 · Sep 29, 2024 | 47.7M sh |
| Stock Repurchased | Q3 2025 · Sep 28, 2025 | $2.9M |
| Stock Repurchased | Q3 2025 · Sep 29, 2024 | $332.6M |
| Capex | Q3 2025 · Sep 28, 2025 | $77.5M |
| Capex | Q3 2025 · Sep 29, 2024 | $54.7M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2025 | $812.3M |
| Operating Cash Flow | Q3 2025 · Sep 29, 2024 | $859.5M |
| Long Term Debt | Q3 2025 · Sep 28, 2025 | $2.08B |
| Long Term Debt | Q3 2025 · Dec 29, 2024 | $2.65B |
| Short Term Debt | Q3 2025 · Sep 28, 2025 | $450.2M |
| Short Term Debt | Q3 2025 · Dec 29, 2024 | $300K |
| Cash And Equivalents | Q3 2025 · Sep 28, 2025 | $528.6M |
| Cash And Equivalents | Q3 2025 · Dec 29, 2024 | $649.8M |
| Stockholders Equity | Q3 2025 · Sep 28, 2025 | $10.56B |
| Stockholders Equity | Q3 2025 · Jun 29, 2025 | $10.38B |
| Stockholders Equity | Q3 2025 · Mar 30, 2025 | $9.93B |
| Stockholders Equity | Q3 2025 · Dec 29, 2024 | $9.55B |
| Stockholders Equity | Q3 2025 · Sep 29, 2024 | $9.59B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $9.32B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $9.33B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $9.22B |
| Current Liabilities | Q3 2025 · Sep 28, 2025 | $1.8B |
| Current Liabilities | Q3 2025 · Dec 29, 2024 | $1.26B |
| Total Liabilities | Q3 2025 · Sep 28, 2025 | $4.81B |
| Total Liabilities | Q3 2025 · Dec 29, 2024 | $4.65B |
| Current Assets | Q3 2025 · Sep 28, 2025 | $3.22B |
| Current Assets | Q3 2025 · Dec 29, 2024 | $2.94B |
| Total Assets | Q3 2025 · Sep 28, 2025 | $15.37B |
| Total Assets | Q3 2025 · Dec 29, 2024 | $14.2B |
| Eps Diluted | Q3 2025 · Sep 28, 2025 | $4.65 |
| Eps Diluted | Q3 2025 · Sep 28, 2025 | $13.06 |
| Eps Diluted | Q3 2025 · Sep 29, 2024 | $5.54 |
| Eps Diluted | Q3 2025 · Sep 29, 2024 | $13.01 |
| Eps Basic | Q3 2025 · Sep 28, 2025 | $4.71 |
| Eps Basic | Q3 2025 · Sep 28, 2025 | $13.23 |
| Eps Basic | Q3 2025 · Sep 29, 2024 | $5.61 |
| Eps Basic | Q3 2025 · Sep 29, 2024 | $13.18 |
| Sga Expense | Q3 2025 · Sep 28, 2025 | $238.2M |
| Sga Expense | Q3 2025 · Sep 28, 2025 | $701.5M |
| Sga Expense restated | Q3 2025 · Sep 29, 2024 | $226.1M |
| Sga Expense restated | Q3 2025 · Sep 29, 2024 | $670.6M |
| Rd Expense | Q3 2025 · Sep 28, 2025 | $83.4M |
| Rd Expense | Q3 2025 · Sep 28, 2025 | $240.1M |
| Rd Expense | Q3 2025 · Sep 29, 2024 | $73M |
| Rd Expense | Q3 2025 · Sep 29, 2024 | $221.2M |
| Net Income | Q3 2025 · Sep 28, 2025 | $220.7M |
| Net Income | Q3 2025 · Sep 28, 2025 | $619.2M |
| Net Income | Q3 2025 · Jun 29, 2025 | $209.9M |
| Net Income | Q3 2025 · Mar 30, 2025 | $188.6M |
| Net Income | Q3 2025 · Sep 29, 2024 | $262M |
| Net Income | Q3 2025 · Sep 29, 2024 | $620.7M |
| Net Income | Q3 2025 · Jun 30, 2024 | $180.2M |
| Net Income | Q3 2025 · Mar 31, 2024 | $178.5M |
| Operating Income | Q3 2025 · Sep 28, 2025 | $282.8M |
| Operating Income | Q3 2025 · Sep 28, 2025 | $820.3M |
| Operating Income | Q3 2025 · Sep 29, 2024 | $270.7M |
| Operating Income | Q3 2025 · Sep 29, 2024 | $752M |
| Cost Of Revenue | Q3 2025 · Sep 28, 2025 | $880M |
| Cost Of Revenue | Q3 2025 · Sep 28, 2025 | $2.58B |
| Cost Of Revenue | Q3 2025 · Sep 29, 2024 | $823.9M |
| Cost Of Revenue | Q3 2025 · Sep 29, 2024 | $2.38B |
| Revenue | Q3 2025 · Sep 28, 2025 | $1.54B |
| Revenue | Q3 2025 · Sep 28, 2025 | $4.5B |
| Revenue | Q3 2025 · Sep 29, 2024 | $1.44B |
| Revenue | Q3 2025 · Sep 29, 2024 | $4.17B |